Epilepsy & Seizures
Epilepsy: treatment in low and middle income countries
Apr. 08, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Professor, Departments of Neurology and Neurosurgery
Director, Comprehensive Epilepsy Program
University of South Florida and Tampa General Hospital
Dr. Benbadis of the University of South Florida and Tampa General Hospital received honorariums from Catalyst, Jazz, LivaNova, Neurelis, SK Life Science, Stratus, and UCB as consultant, speaker, or advisory board member. He received grant support from Cerevel Therapeutics, Elsai, Jazz, LivaNova, Longboard, Marinus, Neuropace, SK Life Science, Takeda UCB, and Xenon Pharmaceuticals.